Search results
U.S. hospitals prone to highly disruptive cyberattacks, experts warn
Washington State Standard via Yahoo News· 19 hours agoIn the wake of a debilitating cyberattack against one of the nation’s largest health care systems,...
Kansas prisons will give doses of opioid antidote to some inmates when they're released
The Topeka Capital-Journal via Yahoo News· 4 days agoIn 2022, more than two-thirds of the overdose deaths in the state were caused by opioids, according...
A ketamine pill may help hard-to-treat depression with fewer side effects, early research suggests
CNN via Yahoo News· 1 day agoThat may have something to do with the way the pills are metabolized, Barnett said. “One of the...
Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes
MedTech Dive via Yahoo Finance· 1 day agoThis story was originally published on MedTech Dive. To receive daily news and insights, subscribe...
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach...
Morningstar· 5 days agoPALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally. Pancreatic cancer becomes more common in the Western
Gilead's Twice-Yearly Shot to Prevent HIV Succeeds in Late-Stage Trial - Slashdot
Slashdot· 3 days agoNone of the roughly 2,000 women in the trial who received the lenacapavir shot had contracted HIV by an interim analysis, prompting the independent data monitoring committee ...
Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression
Clinical Trials Arena via Yahoo Finance· 7 days agoThe submission is expected in the second half of 2024. Data from Study 501, which recruited 485...
MDMA DOA at FDA Advisory Committee
The National Law Review· 5 days agoAvid readers know we have speculated that the legalization of psychedelics as a prescription medicine was “closer than ever.” Unfortunately, for...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 5 days agoThe shot prompts an immune response against a patient's own tumor cells. Almost three-quarters of...
What Can We Really Expect from Elanco's New Bovaer®?
Dairy Herd· 18 hours agoThe first-of-its-kind, methane-reducing feed additive for cattle passed muster with U.S. regulators in May 2024 when the U.S. Food and Drug Administration (FDA) announced a satisfactory review ...
